# Dialysis Indications in Acute Kidney Injury

Initiate kidney replacement therapy urgently for refractory electrolyte, acid-base, fluid, or uremic complications—not creatinine alone. In severe ICU-associated AKI without an emergency indication, structured surveillance and standard initiation avoid unnecessary dialysis without improving survival through accelerated treatment.

**Clinical question:** When should kidney replacement therapy be initiated in adults with acute kidney injury?

Updated: 2026-09-15T21:48:34.234270+00:00

## What matters in practice
- Start kidney replacement therapy without delay for life-threatening hyperkalemia, severe metabolic acidosis, or fluid overload causing refractory pulmonary edema or impaired oxygenation. [1][16][17][21]
- In severe AKI without an urgent indication, accelerated initiation does not reduce 90-day mortality and exposes more patients to dialysis; in STARRT-AKI, only 62% assigned to standard initiation ultimately received kidney replacement therapy. [1][23]
- Use the clinical consequence—not serum creatinine or blood urea nitrogen alone—as the primary trigger; uremic pericarditis, encephalopathy, or bleeding are compelling manifestations requiring treatment. [18][22]
- A watchful standard strategy requires active reassessment for potassium trajectory, pH and bicarbonate, pulmonary edema with hypoxemia, urine output, uremic manifestations, and persistence of severe AKI. [21][23]

## Which AKI complications require urgent dialysis?

Treat immediately correctable threats first, but do not delay kidney replacement therapy when they remain refractory.

Initiate kidney replacement therapy (KRT; also termed renal replacement therapy) urgently when AKI produces life-threatening fluid, electrolyte, or acid-base derangements. The operational bedside triggers are refractory hyperkalemia, severe metabolic acidosis, and pulmonary edema or fluid overload that remains refractory to medical management and compromises respiratory status. [1][16][17][21]

For hyperkalemia, a potassium concentration greater than 6.5 mmol/L, a rapidly rising potassium concentration, or potassium-associated arrhythmia is an absolute indication when conservative measures do not provide durable control. Obtain an ECG while repeating serum potassium when the result is unexpected or hemolysis is possible; escalating potassium despite temporizing therapy should prompt vascular access and KRT planning rather than repeated temporizing interventions alone. [22]

For acidosis, use arterial or venous blood gas results together with bicarbonate and the clinical trajectory. Trial protocols and reviews have used pH less than 7.15 as a severe trigger; other cited criteria include refractory acidosis with pH less than 7.2 or bicarbonate less than 10 mEq/L. A low bicarbonate without severe acidemia or progressive instability does not itself establish an emergency indication; reassess for an accumulating acid load, worsening ventilation, shock, or concurrent hyperkalemia. [2][18][21][22]

For volume overload, initiate KRT when pulmonary edema or fluid overload is diuretic-resistant and causes organ dysfunction, especially severe hypoxemia or impaired oxygenation. Oliguria alone identifies high-risk AKI but is not equivalent to an emergency dialysis indication unless it is accompanied by uncontrolled volume, electrolyte, acid-base, or uremic complications. [1][14][21][22]
- Refractory hyperkalemia: potassium greater than 6.5 mmol/L, rapid rise, or arrhythmia despite conservative management. [22]
- Refractory metabolic acidosis: pH less than 7.15 in major timing trials; pH less than 7.2 or bicarbonate less than 10 mEq/L are also cited operational thresholds. [2][18][21][22]
- Refractory pulmonary edema or fluid overload with hypoxemia or other organ dysfunction. [1][21][22]
- Uremic pericarditis, encephalopathy, or bleeding. [18][22]
- A dialyzable drug or toxin exposure when extracorporeal clearance is indicated. [22]

*Clinical triggers for urgent KRT in AKI; thresholds support action only in the relevant clinical context. [18][21][22]*

| Complication | Actionable finding | Immediate next step |
| --- | --- | --- |
| Hyperkalemia | K+ >6.5 mmol/L, rapid increase, or arrhythmia; refractory to conservative measures [22] | Obtain ECG, treat temporizing instability, and initiate KRT if potassium cannot be durably controlled. [22] |
| Metabolic acidosis | Refractory acidemia; pH <7.15 in major trial criteria, with pH <7.2 or HCO3− <10 mEq/L also cited [2][18][21][22] | Assess ventilation and shock; initiate KRT for persistent severe acid-base derangement. [17][22] |
| Fluid overload | Diuretic-resistant pulmonary edema, severe hypoxemia, or fluid overload causing organ dysfunction [1][21][22] | Escalate to KRT for controlled fluid removal. [1][16] |
| Uremic toxicity | Pericarditis, encephalopathy, or bleeding attributable to uremia [18][22] | Initiate KRT; do not wait for a fixed urea or creatinine threshold. [18][22] |

## When can dialysis be deferred in severe AKI?

In the absence of an emergency indication, use closely monitored standard initiation rather than automatic early dialysis.

For critically ill adults with KDIGO stage 2 or 3 AKI but no emergency indication, do not start KRT solely because AKI has reached a severity stage, serum creatinine has increased, or oliguria is present. In STARRT-AKI, accelerated initiation within 12 hours of qualifying AKI did not improve 90-day mortality or hospital length of stay compared with standard initiation; nearly all accelerated-strategy patients received KRT, whereas only 62% in the standard arm did. [1][23]

The tradeoff is clinically important: an early strategy can expose patients whose renal function would recover to central venous catheter placement, catheter-related infection, anticoagulation-associated bleeding, rapid electrolyte shifts, medication clearance, and other procedure-related harms. Early KRT was also associated with more KRT dependence at 90 days in STARRT-AKI, reported as 10% in the accelerated group. [1][11][23]

Deferral is not passive. It is appropriate only while potassium, acid-base status, pulmonary status, and uremic symptoms remain controlled and the patient can be reassessed frequently. In standard-strategy protocols, KRT was initiated when conventional indications developed or when severe AKI persisted beyond 72 hours. [21][23]
- Do not use an isolated creatinine value as an urgent KRT trigger. [15][17]
- Do not equate oliguria with a mandatory indication; determine whether it has produced refractory volume, metabolic, or uremic complications. [22]
- If choosing deferral, document the reassessment trigger and promptly initiate KRT when a conventional indication emerges. [21][23]

### How long can severe AKI be observed?

Avoid an indefinitely delayed strategy in persistent severe AKI. In AKIKI 2, patients had KDIGO stage 3 AKI with oliguria for more than 72 hours or blood urea nitrogen greater than 112 mg/dL; postponing KRT until a mandatory indication developed or blood urea nitrogen reached 140 mg/dL did not provide additional benefit and was associated with potential harm, including higher 60-day mortality. [23]
- Persistent profound oliguria beyond 72 hours or blood urea nitrogen above 112 mg/dL should trigger a renewed KRT decision rather than routine extension of observation. [23]
- A blood urea nitrogen threshold can inform concern about prolonged severe AKI, but symptoms and complications remain decisive for urgent initiation. [18][22][23]

*Timing evidence favors standard, complication-triggered KRT in ICU AKI without emergency indications. [1][12][23]*

| Clinical state | KRT timing approach | Why |
| --- | --- | --- |
| Life-threatening fluid, electrolyte, or acid-base disorder | Initiate without delay. [16][17] | Urgent correction outweighs uncertainty about elective timing. [1][21] |
| KDIGO stage 2–3 AKI without emergency indication | Use standard initiation with close surveillance rather than automatic initiation within 12 hours. [1][23] | Accelerated initiation did not improve 90-day mortality and treated many patients who did not require KRT under standard care. [1][23] |
| Persistent severe AKI during observation | Reassess repeatedly; avoid extreme postponement beyond prolonged oliguria or marked azotemia. [23] | More-delayed KRT in AKIKI 2 showed potential harm, including higher 60-day mortality. [23] |

## What should be assessed before deciding on dialysis?

Make the decision from the trajectory of complications and reversibility, not from one laboratory value.

At each KRT decision point, obtain a serum chemistry panel with potassium and bicarbonate, assess acidemia with blood gas testing when bicarbonate is low or respiratory compensation is limited, quantify urine output, and evaluate fluid status and oxygenation. The actionable finding is a refractory complication: rising potassium, worsening acidemia, pulmonary edema with severe hypoxemia, or evolving uremic manifestations. [1][18][21][22]

Identify and correct reversible contributors while monitoring for urgent indications. Volume resuscitation with crystalloid is appropriate after evaluation for volume depletion, whereas pulmonary congestion requires a different fluid strategy; balanced crystalloids generally prevent severe hyperchloremia. Reversal of the precipitating hemodynamic, septic, obstructive, or nephrotoxic insult may permit recovery without KRT. [20]

Use a time-limited reassessment plan when KRT is deferred. Escalate immediately for a new emergency indication, and revisit the decision when AKI remains severe beyond 72 hours, oliguria is prolonged, or azotemia is advancing despite correction of reversible factors. [21][23]
- Check potassium trend and ECG when severe hyperkalemia or arrhythmia is suspected. [22]
- Use pH and bicarbonate to distinguish severe refractory acidemia from isolated biochemical acidosis. [2][18][22]
- Assess pulmonary edema by oxygen requirement and response to diuretic therapy; severe hypoxemia from fluid overload favors KRT. [1][21]
- Screen for uremic pericarditis, encephalopathy, and bleeding rather than relying on azotemia alone. [18][22]

*A complication-focused pre-KRT assessment directs whether to treat conservatively, initiate KRT urgently, or continue monitored observation. [1][18][21][22]*

| Assessment domain | Finding that changes management | Decision implication |
| --- | --- | --- |
| Potassium and ECG | K+ >6.5 mmol/L, rapid rise, or arrhythmia despite conservative measures [22] | Urgent KRT if not durably controlled. [22] |
| Blood gas and bicarbonate | Persistent severe acidemia, including pH <7.15 in major trial criteria [2][21] | Urgent KRT when refractory or clinically destabilizing. [17][22] |
| Respiratory and volume assessment | Pulmonary edema refractory to diuretics with severe hypoxemia [1][21] | KRT for controlled fluid removal. [1][22] |
| Neurologic, cardiac, and bleeding assessment | Uremic encephalopathy, pericarditis, or bleeding [18][22] | Initiate KRT for uremic toxicity. [18][22] |
| Duration and trajectory | Severe AKI persists >72 hours, profound oliguria, or BUN rises toward 140 mg/dL [21][23] | Reconsider KRT; do not prolong observation automatically. [23] |

## How should the dialysis modality be selected after the indication is established?

Select the available modality that safely corrects the immediate physiologic problem; timing evidence does not establish a universally superior modality.

Once an indication is present, KRT provides solute control and fluid removal while renal recovery occurs; it does not treat the underlying AKI etiology. Available ICU approaches include intermittent hemodialysis and continuous renal replacement therapy (CRRT), while peritoneal dialysis is a viable alternative in selected AKI settings and is the preferred modality for neonates when feasible. [3][18][21]

Current comparative evidence is insufficient to select one KRT modality over another for all critically ill adults. Choose a modality according to the urgency and magnitude of potassium, acid-base, and fluid correction required, local expertise, access, anticoagulation considerations, and the patient's hemodynamic and respiratory condition; reassess adequacy by potassium, acid-base status, net fluid balance, oxygenation, and uremic manifestations. [4][18]

Do not prescribe KRT merely to prevent possible future complications in a stable patient. The principal advantage of standard timing is avoidance of unnecessary access and treatment-related adverse events in patients who recover kidney function without dialysis. [1][11][12]
- Use KRT as support while treating the precipitating cause of AKI. [18][20]
- Monitor clinical targets—potassium, pH or bicarbonate, volume balance, and oxygenation—rather than assuming that KRT initiation alone resolves the indication. [18][22]
- In sepsis-associated AKI, apply the same accepted KRT indications used for other causes of AKI; earlier initiation has not shown a clear benefit. [12]

*Modality selection should be individualized after a true KRT indication is present. [3][4][18]*

| Option | Role supported by current evidence | Selection consideration |
| --- | --- | --- |
| Intermittent hemodialysis | An established KRT modality used in ICU AKI trials. [21] | Match use to the required solute and fluid control and local operational capability. [4][18] |
| CRRT | An established continuous KRT modality for critically ill AKI. [4][21] | No definitive evidence establishes superiority over other modalities for all patients. [4] |
| Peritoneal dialysis | A viable AKI alternative; preferred for neonates when feasible. [3][5] | Consider when clinically feasible and available. [3] |

## How do sepsis, rhabdomyolysis, and pediatric patients change the threshold?

The indication remains complication-based, but trajectory and feasible modality vary by clinical setting.

In sepsis-associated AKI, use the same accepted KRT indications applied to other AKI etiologies. The IDEAL-ICU trial found no significant survival benefit from earlier KRT compared with standard initiation, and some patients assigned to delayed treatment recovered spontaneously without KRT. [12]

In rhabdomyolysis-associated AKI, do not initiate KRT solely because creatine kinase is elevated. Escalate for refractory hyperkalemia, refractory acidosis, diuretic-resistant pulmonary edema, uremic complications, refractory fluid overload with organ dysfunction, or a dialyzable toxin; progressive AKI with creatinine greater than three times baseline or profound oliguria is a relative—not automatic—indication. [22]

For children, fluid and sodium overload greater than 10% should be considered in the KRT decision, and overload greater than 20% is considered a stronger criterion; these recommendations are expert opinion. Peritoneal dialysis is the KRT modality of choice for neonatal AKI when feasible. [3][16]
- Sepsis does not justify automatic early KRT in the absence of an accepted indication. [12]
- Rhabdomyolysis requires surveillance for potassium, acid-base, and volume complications rather than prophylactic dialysis. [22]
- In pediatric AKI, incorporate cumulative fluid and sodium overload into the KRT threshold. [16]

*Selected settings in which clinical context modifies surveillance or modality, not the core complication-based rationale for KRT. [3][12][16][22]*

| Setting | Decision modifier | KRT implication |
| --- | --- | --- |
| Sepsis-associated AKI | Earlier KRT has not shown significant survival benefit; delayed patients may recover without KRT. [12] | Use conventional urgent indications and close reassessment. [12] |
| Rhabdomyolysis-associated AKI | Creatinine >3 times baseline or profound oliguria is a relative indication; refractory complications are absolute indications. [22] | Do not dialyze on creatine kinase elevation alone. [22] |
| Pediatric AKI | Fluid and sodium overload >10% warrants consideration; >20% is a stronger criterion. [16] | Incorporate cumulative overload alongside conventional complications. [16] |
| Neonatal AKI | Peritoneal dialysis is the modality of choice when feasible. [3] | Use peritoneal dialysis when technical and clinical conditions permit. [3] |

## Common questions

### Does a high blood urea nitrogen level alone mandate dialysis in AKI?

No fixed blood urea nitrogen value universally mandates urgent KRT. Uremic pericarditis, encephalopathy, or bleeding are direct indications. In prolonged severe ICU AKI, blood urea nitrogen above 112 mg/dL should trigger reassessment, while postponement until 140 mg/dL in AKIKI 2 was associated with potential harm. [18][22][23]

### Does oliguria alone require dialysis in acute kidney injury?

No. Oliguria should intensify monitoring for fluid, potassium, and acid-base complications. It becomes a reason to initiate KRT when associated with refractory pulmonary edema, hyperkalemia, acidosis, uremic toxicity, or persistent severe AKI during a time-limited observation strategy. [21][22][23]

## References
1. No Benefit to Early Renal Replacement Therapy for Critically Ill Patients | NEJM Clinician — clinician.nejm.org — https://clinician.nejm.org/no-benefit-early-renal-replacement-therapy-critically-ill-patients-nejm-jw.NA51962
2. Timing of Renal-Replacement Therapy in Patients with Acute Kidney ... — www.nejm.org — https://www.nejm.org/doi/full/10.1056/NEJMoa1803213
3. Continuous renal replacement therapy in neonates and small infants — www.thelancet.com — https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(14)60799-6/fulltext
4. Failing kidneys: renal replacement therapies in the ICU | Trauma Surgery & Acute Care Open — tsaco.bmj.com — https://tsaco.bmj.com/content/9/Suppl_2/e001381
5. Acute kidney injury - References | BMJ Best Practice US — bestpractice.bmj.com — https://bestpractice.bmj.com/topics/en-us/83/references
6. the CRTSAKI Study (Continuous RRT Timing in Sepsis-associated ... — bmjopen.bmj.com — https://bmjopen.bmj.com/content/11/2/e040718
7. Evaluation and Management of Kidney Dysfunction in Advanced ... — www.ahajournals.org — https://www.ahajournals.org/doi/10.1161/CIR.0000000000001273
8. 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection ... — www.ahajournals.org — https://www.ahajournals.org/doi/10.1161/CIR.0000000000001453
9. Cardiovascular Effects of Home Dialysis Therapies: A Scientific ... — www.ahajournals.org — https://www.ahajournals.org/doi/full/10.1161/CIR.0000000000001088?doi=10.1161%2FCIR.0000000000001088
10. Initial continuous renal replacement therapy after stage 3 acute kidney injury without urgent dialysis indications in critically ill adults | Scientific Reports — www.nature.com — https://www.nature.com/articles/s41598-026-53230-y
11. Effects of early dialysis on the outcomes of critically ill patients with acute kidney injury: a systematic review and meta-analysis of randomized controlled trials | Scientific Reports — www.nature.com — https://www.nature.com/articles/s41598-019-54777-9
12. Sepsis-associated acute kidney injury: consensus report of the 28th ... — www.nature.com — https://www.nature.com/articles/s41581-023-00683-3
13. Global epidemiology and outcomes of acute kidney injury | Nature Reviews Nephrology — www.nature.com — https://www.nature.com/articles/s41581-018-0052-0
14. Timing for Initiating Renal Replacement Therapy in Patients ... : Journal of Translational Critical Care Medicine — journals.lww.com — https://journals.lww.com/jtccm/fulltext/2022/01000/timing_for_initiating_renal_replacement_therapy_in.2.aspx
15. Indications and timing of renal replacement... : Critical Care Medicine — journals.lww.com — https://journals.lww.com/ccmjournal/fulltext/2008/04001/indications_and_timing_of_renal_replacement.14.aspx
16. Critical Care in Renal Replacement Therapy - ScienceDirect.com — www.sciencedirect.com — https://www.sciencedirect.com/topics/medicine-and-dentistry/critical-care-in-renal-replacement-therapy
17. The Timing of Renal Replacement Therapy Initiation in Acute Kidney Injury — www.sciencedirect.com — https://www.sciencedirect.com/science/article/abs/pii/S0270929516000103
18. Renal Replacement - an overview | ScienceDirect Topics — sciencedirect.com — https://sciencedirect.com/topics/medicine-and-dentistry/renal-replacement
19. Acute renal replacement therapy in cardiogenic shock: Prognostic impact of timing, modality, and indications – Insights from the FRENSHOCK study - ScienceDirect — www.sciencedirect.com — https://www.sciencedirect.com/science/article/abs/pii/S0883944125003910
20. Updates in Management and Timing of Dialysis in Acute Kidney Injury - Yu - 2019 - Journal of Hospital Medicine - Wiley Online Library — shmpublications.onlinelibrary.wiley.com — https://shmpublications.onlinelibrary.wiley.com/doi/10.12788/jhm.3105
21. Timing of renal replacement therapy initiation for acute kidney injury in critically ill patients: a systematic review of randomized clinical trials with meta-analysis and trial sequential analysis - PMC — pmc.ncbi.nlm.nih.gov — https://pmc.ncbi.nlm.nih.gov/articles/PMC7789484
22. Critical care considerations in rhabdomyolysis-associated acute kidney injury and kidney replacement therapy — pmc.ncbi.nlm.nih.gov — https://pmc.ncbi.nlm.nih.gov/articles/PMC13324666
23. Treatment of Acute Kidney Injury: A Review of Current Approaches and Emerging Innovations — pmc.ncbi.nlm.nih.gov — https://pmc.ncbi.nlm.nih.gov/articles/PMC11084889
24. When and why to start continuous renal replacement therapy in critically ill patients with acute kidney injury — pmc.ncbi.nlm.nih.gov — https://pmc.ncbi.nlm.nih.gov/articles/PMC8685358

## Editorial note

Prepared from cited clinical literature using Astra's research workflow. Verify recommendations against current guidance and patient-specific factors.